ArticleNaunyn-Schmiedeberg's archives of pharmacology2021

Fibroblast growth factor 21: a novel long-acting hypoglycemic drug for canine diabetes.

Xinghao Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.